Skip to content

Rifamycin Sv

Published: July 26, 2026Updated: August 25, 2026

Rifamycin SV is a rifamycin-class antibiotic used to treat infectious diarrhea and traveler's diarrhea caused by susceptible non-invasive strains of E. coli, and to reduce the risk of hepatic encephalopathy.

Quick summary

Rifamycin SV is an intestinal antibiotic primarily used for traveler's diarrhea and reducing hepatic encephalopathy risk.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ATC
A07AA13
RxNorm
35616
Generic
Rifamycin Sv
Class
atc-a07
Brands
Aemcolo
Availability
rx
Lactation
unknown
Routes
oral
Forms
tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of acute, non-invasive traveler's diarrhea caused by susceptible strains of Escherichia coli in adults and children 12 years and older. Also used as an adjuvant therapy for reducing risk of overt hepatic encephalopathy recurrence in adults with liver cirrhosis.

Rifamycin SV is a bactericidal antibiotic that inhibits bacterial DNA-dependent RNA polymerase, preventing bacterial protein synthesis. It has a broad spectrum of activity against gram-positive and gram-negative bacteria, though oral administration results in minimal systemic absorption, allowing for localized action in the gastrointestinal tract.

Common side effects include headache, abdominal pain, and constipation. May cause harmless red-orange discoloration of feces, urine, saliva, sweat, and tears. Not recommended for patients with known hypersensitivity to rifamycin-class antibiotics. Should not be used for diarrhea complicated by fever or bloody stools. Effectiveness in treating traveler's diarrhea caused by pathogens other than E. coli has not been established.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy